GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Accounts Receivable

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Accounts Receivable : $320 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Sartorius Stedim Biotech's accounts receivables for the quarter that ended in Dec. 2023 was $320 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Sartorius Stedim Biotech's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 37.93.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Sartorius Stedim Biotech's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-51.16.


Sartorius Stedim Biotech Accounts Receivable Historical Data

The historical data trend for Sartorius Stedim Biotech's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Accounts Receivable Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 227.06 295.52 382.94 428.60 320.39

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 428.60 387.58 350.81 326.36 320.39

Sartorius Stedim Biotech Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Sartorius Stedim Biotech Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Sartorius Stedim Biotech's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=320.393/770.774*91
=37.93

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Sartorius Stedim Biotech's accounts receivable are only considered to be worth 75% of book value:

Sartorius Stedim Biotech's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(127.154+0.75 * 320.393+0.5 * 962.268-5525.3
-0-38.495)/92.165
=-51.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Sartorius Stedim Biotech Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Headlines

From GuruFocus

Sartorius Stedim Biotech closes acquisition of BIA Separations

By PRNewswire PRNewswire 11-02-2020

Sartorius Postpones Annual Shareholders' Meeting

By PRNewswire PRNewswire 03-17-2020

Preliminary results 2021 of Sartorius Stedim Biotech

By PRNewswire PRNewswire 01-31-2022

Sartorius Stedim Biotech With a Strong Start in 2020

By PRNewswire PRNewswire 04-21-2020

Nine-month results of Sartorius Stedim Biotech

By PRNewswire PRNewswire 10-20-2021

Strong profitable growth at Sartorius Stedim Biotech

By PRNewswire PRNewswire 10-20-2020

First-quarter results 2022 of Sartorius Stedim Biotech

By PRNewswire PRNewswire 04-21-2022